Researcher.Life Logo

British Journal of Pharmacology : Impact Factor & More

eISSN: 1476-5381pISSN: 0007-1188

Aims and Scope of British Journal of Pharmacology

The British Journal of Pharmacology is a biweekly peer-reviewed medical journal covering all aspects of experimental pharmacology. It is published for the British Pharmacological Society by Wiley-Blackwell. It was established in 1946 as the British Journal of Pharmacology and Chemotherapy. The journal obtained its current title in 1968. Less

Key Metrics

CiteScore
13.6
Eigenfactor
0.01 - 0.05
Impact Factor
5 - 10
Scite Index
0.92 5-Year SI
SJR
Q1Pharmacology
SNIP
1.87
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on British Journal of Pharmacology

British Journal of Pharmacology Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Semi-monthly
General Details
LanguageEnglish
FrequencySemi-monthly
Publication Start Year1946
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in British Journal of Pharmacology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in British Journal of Pharmacology

Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance.
  • 1 Jun 2026
  • British journal of pharmacology
Lysine demethylase 1A alleviates Alzheimer disease progression by regulating the leucine carboxyl methyltransferase 1/protein phosphatase 2 catalytic subunit alpha/transcription factor EB pathway via O-GlcNAcase-mediated forkhead box transcription factor A2 O-GlcNAcylation modification.
  • 1 Jun 2026
  • British journal of pharmacology
Second-generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy-induced toxicity.
  • 1 Jun 2026
  • British journal of pharmacology
Dissociating role of Bassoon in glutamatergic and dopaminergic neurons in alcohol-related behaviour and affective state in mice.
  • 1 Jun 2026
  • British journal of pharmacology
GW201 mediates neuroprotection via allosteric modulation of NMDA receptor activity in the middle cerebral artery occlusion (MCAO) model.
  • 1 Jun 2026
  • British journal of pharmacology
Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis.
  • 1 Jun 2026
  • British journal of pharmacology
Thrombospondin-4 is upregulated in abdominal aortic aneurysm: A vasoprotective response with potential therapeutic relevance.
  • 1 Jun 2026
  • British journal of pharmacology
Lysine demethylase 1A alleviates Alzheimer disease progression by regulating the leucine carboxyl methyltransferase 1/protein phosphatase 2 catalytic subunit alpha/transcription factor EB pathway via O-GlcNAcase-mediated forkhead box transcription factor A2 O-GlcNAcylation modification.
  • 1 Jun 2026
  • British journal of pharmacology
Second-generation prokineticin PKR1 receptor agonists: Advancing cardioprotection against chemotherapy-induced toxicity.
  • 1 Jun 2026
  • British journal of pharmacology
Dissociating role of Bassoon in glutamatergic and dopaminergic neurons in alcohol-related behaviour and affective state in mice.
  • 1 Jun 2026
  • British journal of pharmacology
GW201 mediates neuroprotection via allosteric modulation of NMDA receptor activity in the middle cerebral artery occlusion (MCAO) model.
  • 1 Jun 2026
  • British journal of pharmacology
Noncanonical function of sphingosine kinase 2 (SPHK2) sustains hepatic triglyceride homeostasis.
  • 1 Jun 2026
  • British journal of pharmacology

FAQs on British Journal of Pharmacology